These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 24258305)
21. Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study. Eisenga MF; De Jong MA; Van der Meer P; Leaf DE; Huls G; Nolte IM; Gaillard CAJM; Bakker SJL; De Borst MH PLoS Med; 2019 Jun; 16(6):e1002818. PubMed ID: 31170159 [TBL] [Abstract][Full Text] [Related]
35. FGF23 analysis of a Chinese family with autosomal dominant hypophosphatemic rickets. Sun Y; Wang O; Xia W; Jiang Y; Li M; Xing X; Hu Y; Liu H; Meng X; Zhou X J Bone Miner Metab; 2012 Jan; 30(1):78-84. PubMed ID: 21710177 [TBL] [Abstract][Full Text] [Related]
36. [Value of serum fibroblast growth factor 23 in diagnosis of hypophosphatemic rickets in children]. Dong SS; Che RC; Zheng BX; Zhang AH; Wang CL; Bai M; Chen Y Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jul; 25(7):705-710. PubMed ID: 37529952 [TBL] [Abstract][Full Text] [Related]
37. Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women. Wolf M; Koch TA; Bregman DB J Bone Miner Res; 2013 Aug; 28(8):1793-803. PubMed ID: 23505057 [TBL] [Abstract][Full Text] [Related]
38. Fibroblast growth-factor 23 and vitamin D are associated with iron deficiency and anemia in children with chronic kidney disease. Karava V; Dotis J; Kondou A; Christoforidis A; Taparkou A; Farmaki E; Economou M; Printza N Pediatr Nephrol; 2023 Aug; 38(8):2771-2779. PubMed ID: 36862253 [TBL] [Abstract][Full Text] [Related]
39. Pathogenic role of Fgf23 in Dmp1-null mice. Liu S; Zhou J; Tang W; Menard R; Feng JQ; Quarles LD Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E254-61. PubMed ID: 18559986 [TBL] [Abstract][Full Text] [Related]
40. C-Terminal, but Not Intact, FGF23 and EPO Are Strongly Correlatively Elevated in Patients With Gain-of-Function Mutations in HIF2A: Clinical Evidence for EPO Regulating FGF23. Roszko KL; Brown S; Pang Y; Huynh T; Zhuang Z; Pacak K; Collins MT J Bone Miner Res; 2021 Feb; 36(2):315-321. PubMed ID: 33049075 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]